MedMen Enterprises, one of the most prominent companies in the expanding cannabis industry, agreed to buy medical pot firm PharmaCann for $682 million, boosting its presence across the U.S. The all-stock purchase, which will give MedMen 10 additional dispensaries and licenses for several more,...